• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳比隆:一种用于开角型青光眼的减压合成苯并吡喃。

Nabilone: a pressure-reducing synthetic benzopyran in open-angle glaucoma.

作者信息

Newell F W, Stark P, Jay W M, Schanzlin D J

出版信息

Ophthalmology. 1979 Jan;86(1):156-60. doi: 10.1016/s0161-6420(79)35539-7.

DOI:10.1016/s0161-6420(79)35539-7
PMID:530560
Abstract

Nabilone is a synthesized crystalline benzopyran that resembles the cannabinols but is not a tetrahydrocannabinol. Oral administration of 0.5 to 2 mg to patients with open-angle glaucoma reduced the intraocular pressure from 10% to 54% with an average of 28%. Administration of a topical ophthalmic nabilone solution (0.1 mg/drop) to both eyes of adult albino rabbits (1.5 to 3.5 kg) lowered the IOP an average of 25%. The peak action of the nabilone administered in this manner was 60 minutes, with a return to normal IOP by 180 minutes. Tolerance developed in rabbits after one week of topical administration.

摘要

纳必隆是一种合成的结晶性苯并吡喃,它类似于大麻酚,但不是四氢大麻酚。给开角型青光眼患者口服0.5至2毫克纳必隆,可使眼压降低10%至54%,平均降低28%。给成年白化兔(体重1.5至3.5千克)双眼局部应用纳必隆眼药水(0.1毫克/滴),平均可使眼压降低25%。以这种方式给药的纳必隆的峰值作用时间为60分钟,180分钟后眼压恢复正常。局部给药一周后,兔子产生了耐受性。

相似文献

1
Nabilone: a pressure-reducing synthetic benzopyran in open-angle glaucoma.纳比隆:一种用于开角型青光眼的减压合成苯并吡喃。
Ophthalmology. 1979 Jan;86(1):156-60. doi: 10.1016/s0161-6420(79)35539-7.
2
Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.全身应用乙酰唑胺与局部应用多佐胺联合降低眼压及房水生成
Ophthalmology. 1998 Jan;105(1):88-92; discussion 92-3. doi: 10.1016/s0161-6420(98)91421-x.
3
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.一氧化氮合酶抑制剂的局部应用可降低实验性青光眼兔的眼压。
J Ocul Pharmacol Ther. 2003 Dec;19(6):527-34. doi: 10.1089/108076803322660440.
4
Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.PF-04217329 是一种选择性前列腺素 EP(2)激动剂前药,对青光眼的临床前模型中的眼压的影响。
Exp Eye Res. 2011 Sep;93(3):256-64. doi: 10.1016/j.exer.2011.02.015. Epub 2011 Mar 3.
5
Intraocular pressure lowering effects of novel arylpiperazine derivatives.
J Ocul Pharmacol Ther. 1998 Aug;14(4):313-22. doi: 10.1089/jop.1998.14.313.
6
Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months.比较研究表施妥(timolol)和异搏定(verapamil)在 6 个月内对青光眼患者的局部应用。
J Ocul Pharmacol Ther. 2009 Dec;25(6):551-3. doi: 10.1089/jop.2009.0005.
7
The effect of d-isoproterenol on intraocular pressure of the rabbit, monkey, and man.d-异丙肾上腺素对兔、猴和人眼压的影响。
Invest Ophthalmol. 1976 Feb;15(2):113-8.
8
Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma.在正常眼压性青光眼患者中,每天一次使用拉坦前列素治疗可降低眼压。
Ophthalmology. 1996 Aug;103(8):1276-82. doi: 10.1016/s0161-6420(96)30510-1.
9
Latanoprost : an update of its use in glaucoma and ocular hypertension.拉坦前列素:其在青光眼和高眼压症治疗中的应用进展
Drugs Aging. 2003;20(8):597-630. doi: 10.2165/00002512-200320080-00005.
10
Clonidine. Effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma.可乐定。局部给药溶液对开角型青光眼眼压和血压的影响。
Arch Ophthalmol. 1977 Aug;95(8):1368-73. doi: 10.1001/archopht.1977.04450080078007.

引用本文的文献

1
Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.大麻及大麻素对眼部的不良影响与新出现的治疗潜力:一项叙述性综述
Clin Ophthalmol. 2024 Nov 29;18:3529-3556. doi: 10.2147/OPTH.S501494. eCollection 2024.
2
Ocular effects of synthetic cannabinoids: a case-control study.合成大麻素的眼部效应:一项病例对照研究。
Eye (Lond). 2025 Jan;39(1):94-101. doi: 10.1038/s41433-024-03381-x. Epub 2024 Oct 8.
3
Therapeutic Potential of Cannabinoids in Glaucoma.大麻素在青光眼治疗中的潜在应用
Pharmaceuticals (Basel). 2023 Aug 14;16(8):1149. doi: 10.3390/ph16081149.
4
Cannabinoids in Glaucoma Patients: The Never-Ending Story.青光眼患者体内的大麻素:永无休止的故事。
J Clin Med. 2020 Dec 8;9(12):3978. doi: 10.3390/jcm9123978.
5
Nabilone. A preliminary review of its pharmacological properties and therapeutic use.纳必隆。其药理特性与治疗用途的初步综述。
Drugs. 1985 Aug;30(2):127-44. doi: 10.2165/00003495-198530020-00002.
6
Retention of topical liposomal formulations on the cornea.局部脂质体剂型在角膜上的滞留情况。
Experientia. 1990 Jul 15;46(7):713-5. doi: 10.1007/BF01939943.